Cases 11 - 20 of 275
Astellas Pharma, Inc. v. Sandoz Inc.
as 23-2032
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
SANDOZ INC., PRINSTON PHARMACEUTICAL INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
NOVO NORDISK INC. et al v. LUPIN LTD.
as 3:2023cv04027
Plaintiff:
NOVO NORDISK INC. and NOVO NORDISK A/S
Defendant:
LUPIN LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma, Inc. v. Aurobindo Pharma Ltd.
as 23-2089
Plaintiff / Appellant:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant / Appellee:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC and others
BAUSCH & LOMB, INC. et al v. LUPIN LTD.
as 3:2023cv02452
Plaintiff:
BAUSCH & LOMB, INC., BAUSCH & LOMB IRELAND LIMITED and EYE THERAPIES, LLC
Defendant:
LUPIN LTD., LUPIN ATLANTIS HOLDINGS SA, LUPIN INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH & LOMB INCORPORATED et al v. LUPIN LTD. et al
as 2:2023cv02664
Plaintiff:
BAUSCH & LOMB INCORPORATED and BAUSCH + LOMB IRELAND LIMITED
Defendant:
LUPIN LTD., LUPIN ATLANTIS HOLDINGS SA, LUPIN INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re Novartis and Par Antitrust Litigation
as 1:2018cv04361
Defendant:
Endo Pharmaceuticals, Inc., Par Pharmaceutical, Inc., Novartis Pharmaceuticals Corporation and others
Plaintiff:
Drogueria Betances, LLC, H-E-B LP, Rite Aid Hdqtrs. Corp., and others
Consolidated Plaintiff:
Law Enforcement Health Benefits Inc., Turlock Irrigation District and UFCW Local 1500 Welfare Fund
Respondent:
Mylan Pharmaceuticals, Inc.
Not Classified By Court:
Lupin Ltd., Lupin Pharmaceuticals, Inc., OptumRX, Inc. and others
Interested Party:
Caremark PHC, LLC and Mylan Pharmaceuticals Inc.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al
as 1:2023cv00229
Plaintiff:
Catalyst Pharmaceuticals, Inc. and SERB SA
Defendant:
Lupin Ltd., Lupin Inc. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. LUPIN LTD. et al
as 2:2023cv01197
Plaintiff:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Defendant:
LUPIN LTD., LUPIN INC. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2022cv01465
Plaintiff:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc. and Springcare USA LLC doing business as Spring Bio Solution
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
